Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9999
-0.05-4.77%
At close: -
$1.03
0.033.01%
After Hours: Apr 4, 9:26 AM EDT
Comments
Loading...
Repare Therapeutics Analyst Ratings and Price Targets | NASDAQ:RPTX | Benzinga
Repare Therapeutics Inc has a consensus price target of $12 based on the ratings of 5 analysts. The high is $25 issued by Piper Sandler on October 16, 2023. The low is $4 issued by Stifel on December 13, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Stifel, and HC Wainwright & Co. on March 7, 2025, December 13, 2024, and November 8, 2024, respectively. With an average price target of $6.33 between HC Wainwright & Co., Stifel, and HC Wainwright & Co., there's an implied 514.89% upside for Repare Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Stifel
Piper Sandler
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Repare Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | Buy Now | 385.44% | HC Wainwright & Co. | Robert Burns41% | $10 → $5 | Maintains | Buy | Get Alert |
| 12/13/2024 | Buy Now | — | LifeSci Capital | Charles Zhu60% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/13/2024 | Buy Now | 288.35% | Stifel | Benjamin Burnett43% | $9 → $4 | Maintains | Buy | Get Alert |
| 11/08/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 10/24/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 09/23/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 09/04/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 02/14/2024 | Buy Now | 870.87% | HC Wainwright & Co. | Robert Burns41% | $25 → $10 | Maintains | Buy | Get Alert |
| 11/20/2023 | Buy Now | 2327.18% | HC Wainwright & Co. | Robert Burns41% | → $25 | Reiterates | Buy → Buy | Get Alert |
| 10/16/2023 | Buy Now | 2327.18% | Piper Sandler | Joseph Catanzaro41% | $30 → $25 | Maintains | Overweight | Get Alert |
| 09/25/2023 | Buy Now | 1550.49% | Stifel | Benjamin Burnett43% | $16 → $17 | Maintains | Buy | Get Alert |
| 08/17/2023 | Buy Now | 2327.18% | HC Wainwright & Co. | Robert Burns41% | $26 → $25 | Maintains | Buy | Get Alert |
| 06/09/2023 | Buy Now | 1453.4% | Stifel | Benjamin Burnett43% | $11 → $16 | Upgrade | Hold → Buy | Get Alert |
| 06/09/2023 | Buy Now | 2424.27% | HC Wainwright & Co. | Robert Burns41% | $25 → $26 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 2327.18% | HC Wainwright & Co. | Robert Burns41% | → $25 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | Buy Now | 2327.18% | HC Wainwright & Co. | Robert Burns41% | → $25 | Reiterates | → Buy | Get Alert |
| 02/27/2023 | Buy Now | 1259.22% | Morgan Stanley | Jeffrey Hung52% | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | Buy Now | 1356.31% | Morgan Stanley | Jeffrey Hung52% | $28 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/17/2022 | Buy Now | 2327.18% | HC Wainwright & Co. | Robert Burns41% | $38 → $25 | Maintains | Buy | Get Alert |
| 08/08/2022 | Buy Now | 2618.45% | Morgan Stanley | Jeffrey Hung52% | $30 → $28 | Maintains | Overweight | Get Alert |
| 06/06/2022 | Buy Now | 3589.32% | HC Wainwright & Co. | Robert Burns41% | $54 → $38 | Maintains | Buy | Get Alert |
| 06/02/2022 | Buy Now | 2812.62% | Piper Sandler | Joseph Catanzaro41% | $25 → $30 | Maintains | Overweight | Get Alert |
| 04/12/2022 | Buy Now | 967.96% | Stifel | Benjamin Burnett43% | $45 → $11 | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Repare Therapeutics (RPTX) stock?
The latest price target for Repare Therapeutics (NASDAQ:RPTX) was reported by HC Wainwright & Co. on March 7, 2025. The analyst firm set a price target for $5.00 expecting RPTX to rise to within 12 months (a possible 385.44% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Repare Therapeutics (RPTX)?
The latest analyst rating for Repare Therapeutics (NASDAQ:RPTX) was provided by HC Wainwright & Co., and Repare Therapeutics maintained their buy rating.
When was the last upgrade for Repare Therapeutics (RPTX)?
The last upgrade for Repare Therapeutics Inc happened on June 9, 2023 when Stifel raised their price target to $16. Stifel previously had a hold for Repare Therapeutics Inc.
When was the last downgrade for Repare Therapeutics (RPTX)?
The last downgrade for Repare Therapeutics Inc happened on December 13, 2024 when LifeSci Capital changed their price target from N/A to N/A for Repare Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Repare Therapeutics (RPTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Repare Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Repare Therapeutics was filed on March 7, 2025 so you should expect the next rating to be made available sometime around March 7, 2026.
Is the Analyst Rating Repare Therapeutics (RPTX) correct?
While ratings are subjective and will change, the latest Repare Therapeutics (RPTX) rating was a maintained with a price target of $10.00 to $5.00. The current price Repare Therapeutics (RPTX) is trading at is $1.03, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.